Skip to main content
Chabiotech Co.,Ltd. logo

Chabiotech Co.,Ltd. — Investor Relations & Filings

Ticker · 085660 ISIN · KR7085660009 KO Professional, scientific and technical activities
Filings indexed 460 across all filing types
Latest filing 2024-12-19 Major Shareholding Noti…
Country KR South Korea
Listing KO 085660

About Chabiotech Co.,Ltd.

http://en.chabio.com/

Chabiotech Co., Ltd. is a biotechnology company specializing in the research and development of cell and gene therapies for rare cancers and incurable diseases. The company's core activities include advancing its therapeutic pipelines and providing global Contract Development and Manufacturing Organization (CDMO) services for advanced biopharmaceuticals, including full-scale GMP production and testing. Chabiotech also operates bio-banking services, such as cord blood and immune/stem cell storage, utilizing advanced cryopreservation technology. Its diversified business segments extend to genomics for precision medicine, healthcare IT solutions that integrate AI and Big Data, comprehensive wellness programs, and specialized healthcare consulting.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status of Cha Kwang-yul and his special related parties in CHA Biotech. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant ownership levels and related contractual obligations (such as stock collateral agreements).
2024-12-19 Korean
전환주식의전환가액조정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Cha Biotech regarding the adjustment of the conversion price of convertible preferred shares due to a decline in market price. This type of disclosure, which details changes to capital structure instruments like convertible securities, falls under the category of capital and financing updates.
2024-12-17 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price of convertible bonds (CB) due to a decline in the company's stock price. This type of disclosure, which details changes to capital structure instruments like convertible debt, falls under the 'Capital/Financing Update' category.
2024-12-16 Korean
신주인수권행사가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Cha Biotech regarding the adjustment of the exercise price of stock warrants (신주인수권행사가액의 조정) due to a decline in market price. This type of filing relates to changes in capital structure and potential future share issuance resulting from warrant exercises. Among the provided categories, 'SHA' (Share Issue/Capital Change) is the most appropriate classification as it covers adjustments to capital instruments and share-related rights.
2024-12-16 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a formal notice from Cha Biotech regarding the setting of a record date and the closure of the shareholder register for the purpose of determining shareholders eligible to vote at the 23rd Annual General Meeting. This type of regulatory disclosure, which informs the market of administrative actions related to shareholder meetings, is classified as a general regulatory filing.
2024-12-16 Korean
주요사항보고서(교환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Services Commission and the Korea Exchange. It specifically details the decision to issue exchangeable bonds (교환사채권 발행결정), including terms, interest rates, maturity, and use of proceeds. This falls under the category of capital and financing updates.
2024-12-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.